Hyperhomocysteinemia as the main thrombophilic risk marker in COPD

E. Abduganieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan)

Source: International Congress 2022 – Exacerbations in COPD: biomarkers and management

Session: Exacerbations in COPD: biomarkers and management
Session type: Thematic Poster
Number: 209

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Abduganieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan). Hyperhomocysteinemia as the main thrombophilic risk marker in COPD. 209

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.